The utility of fetal fibronectin in the prediction and prevention of spontaneous preterm birth.
Publication/Presentation Date
1-1-2008
Abstract
Spontaneous preterm birth remains a significant problem in the United States despite intense research to decrease its prevalence. Strategies have been limited by inability to identify patients at risk for preterm birth, as the majority of patients do not have historical risk factors. The development of an assay to detect vaginal fetal fibronectin, along with the use of transvaginal ultrasonography to determine cervical length, has greatly increased our ability to identify those patients at highest risk. This article reviews the most significant studies on this topic, providing a context for suggested management algorithms for both symptomatic and asymptomatic patients at risk for spontaneous preterm birth.
Volume
1
Issue
3
First Page
106
Last Page
112
ISSN
1941-2797
Published In/Presented At
Kiefer, D. G., & Vintzileos, A. M. (2008). The utility of fetal fibronectin in the prediction and prevention of spontaneous preterm birth. Reviews in obstetrics & gynecology, 1(3), 106–112.
Disciplines
Medicine and Health Sciences
PubMedID
19015761
Department(s)
Department of Obstetrics and Gynecology
Document Type
Article